Quantum Kinetics Corporation (QKC) claimed that it successfully triggered plasma fusion temperatures of 392 million degrees ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Vector-borne diseases, such as malaria and yellow fever ... Her work has earned her recognition as a trusted voice in Nigeria’s health journalism field.

Partly in light of three new Arm Cortex CPUs launching at Computex in June, Chris Bergey, Arm Senior Vice President and ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.